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Abstract 
Objective: The main objective was to estimate a preference-based SF-6D index from the SF-
36 for Japan and compare to the UK results. 
Study design and setting:  The SF-6D was translated into Japanese.  249 health states defined 
by this version of the SF-6D were then valued by a representative sample of 600 members of 
the Japanese general population using standard gamble. These health state values were 
modelled using classical parametric random effects methods with individual level data and 
OLS on mean health state values, together with a new nonparametric approach using 
Bayesian methods of estimation.   
Results: All parametric models estimated on Japanese data were found to perform less well 
than their UK counterparts in terms of poorer goodness of fit, more inconsistencies, larger 
prediction errors and bias, and evidence of systematic bias in the predictions.  Non-parametric 
models produce a substantial improvement in out of sample predictions.  The physical, role 
and social dimensions have relatively larger decrements than pain and mental health 
compared to the UK.  
Conclusion: The differences between Japan and UK valuation of the SF-6D make it important 
to use the Japanese valuation data set estimated using the non-parametric Bayesian technique 
presented in this paper.   
 
Key words: Preference-based measures, QALYs, SF-6D, Bayesian modelling, Japan, cross- 
cultural comparisons 
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BACKGROUND 
Preference-based measures of health standardized, multidimensional systems for classifying 
health states that generate scores on a scale where full health is one and zero is equivalent to 
death. [1] The use of preference-based measures of health has grown considerably over the 
last decade with the increasing use of economic evaluation to inform health policy.   
 
The SF-36 is one of the most widely used generic health survey instruments. [2] There is 
substantial evidence of the ability of the eight dimension scores of the SF-36 to describe the 
health differences between patient groups and to track changes over time.  However, the 
methods for scoring the SF-36 are not preference-based and do not provide a means to derive 
QALYs.  The SF-6D was developed as a practical tool for obtaining a preference-based index 
from SF-36 data. [3] 
 
Given the high cost of undertaking valuation surveys, early work using preference-based 
measures has tended to use the valuation results from just one or two countries, which for the 
EQ-5D [4] and SF-6D has been the UK and for the HUI [5] has been Canada.  However, 
significant differences have been found between countries, for example values obtained in the 
UK EQ-5D surveys and those from Japan [6] and USA [7] and between Canadian values for 
the HUI2 and those obtained in the UK [8]. This paper presents results from undertaking a 
valuation of the SF-6D in Japan and compares it to results for the UK. 
 
An important problem for preference-based measures has been their size and the consequent 
need to model health state values from valuation of a subset of possible states.  Classical 
modelling with random effects estimated using generalised least squares (GLS)  has met with 
some success, but has encountered major challenges due to the nature of the distribution of 
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health state values which is generally skewed, truncated, hierarchical and non-continuous 
[10].  An alternative non-parametric model has been developed to estimate health state values 
by Bayesian methods [11].  The nonparametric method was applied to the UK valuation data 
set and was found to achieve a better predictive model and so has replaced the original UK 
preference-based scoring algorithm.  For this reason, it was felt to be important to apply this 
approach to the valuation data from Japan and compare it to the classical random effects 
model.   
 
METHODS 
The methods closely follows those used the UK to derive the SF-6D preference-based 
measure of health from the SF-36. [3] The first stage in the UK study was to develop the SF-
6D, a health state classification with six dimensions (physical functioning, role limitation, 
social functioning, bodily pain, mental health and vitality).  The six dimensions have between 
four and six that define a total of 18000 health states. A selection of 249 SF-6D health states 
were valued by a representative sample of the UK general population using the standard 
gamble (SG) valuation technique.  The resultant valuation data were modelled to generate a 
UK algorithm for valuing all SF-6D states. These methods required some modification for use 
in Japan.    
 
Translation of the SF-6D 
The SF-6D uses items of the SF-36, so it was possible to use an existing translation of the SF-
36 undertaken by Fukuhara and colleagues [10].  The only item that required modification 
was the role dimension.  This dimension was changed to ask the frequency of role limitation 
induced by general health states, for both role-emotional and role-physical showed same 
pattern in the SF-36 survey in Japan. Previous work with the SF-36 in Japan had found that 
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the emotional dimension did not perform in the same way as in the west and reflected a 
different cultural perception of health [11].  The second modification was to use the item from 
version 2 of SF-36 since it has 5 levels per item rather than the two in version 1 and so 
provides a better spread of responses.   
 
The resultant Japanese SF-6D is a multi-level six dimensional health state classification and 
this is presented in English on Table 1.   
 
Valuation survey 
A sub-set of health states defined by the SF-6D were valued by a representative sample of the 
general public in Japan. Each respondent was asked to rank and value seven states using a 
variant of the SG technique.  The key design components of the survey were the selection of 
health states, the sampling of respondents and the conduct of the interviews. 
 
Selection of health states   
It was not possible to use the same health state sample as used in the UK study, since the 
Japanese version of the SF-6D had been modified.  The sample of states was selected using an 
orthogonal design (by applying the orthoplan procedure of SPSS), which generates the states 
needed to estimate an additive model supplemented by an additional sample obtained at 
random.  Two hundred and forty states were generated in this way. On inspection of the 
states, it was found that there were 10 infeasible states, such as ‘extreme pain’ alongside ‘no 
problems’ in the social and/or role dimensions.  For these states, the levels of role and social 
were changed to level 3.  
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Respondents valued 6 intermediate states and the worst SF-6D health state. The 6 
intermediate states for each interview were selected using a block system. The 240 states were 
divided into 6 severity categories using a total score based on the sum of dimension level 
scores.  Five blocks of 48 were created by taking random samples of 8 states from each 
severity category.  Each interviewer received one or two blocks of 48 cards. For each block 
the interviewers randomly sorted the states into 8 sets of 6 states for the interviews.  This 
block system ensured that each person valued a range of health states across the space defined 
by the SF-6D and it was also designed to maximise the chance that each of the 240 cards 
would be valued by an equal number of respondents.   
 
Selection of respondents   
The aim was to ensure the sample reflected the variability in the population of characteristics 
such as age, socio-economic status and level of education. This was achieved by a two-stage 
cluster random design where 50 districts were randomly selected across Japan.  Quota 
sampling was then applied using variables for age, education, income and type of occupation.  
The target was 600 respondents since this was found to be sufficient in the UK study.  
 
The Interviews 
Trained interviewers conducted the survey, interviewing respondents in their own home. The 
interview began with the respondent being asked to complete a short self-completion 
questionnaire about his or her own state of health, that included the SF-6D. This familiarised 
the respondent with the idea of describing health in terms of the SF-6D. Other self-report 
questionnaires used in the survey were the SF-36, SF-8, EQ-5D and EQ-5D-VAS.   
The respondent was asked to rank a set of nine cards: one for each of the intermediate health 
states they would have to value (6), along with the best state defined by the SF-6D, the worst 
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state and being dead. Next respondents were asked to value health states using a variant of the 
SG that uses a Chance Board to display probabilities. [12].   
In the SG valuation task respondents were asked to value each intermediate SF-6D health 
states against the uncertain prospect of ending up in the best or worst SF-6D health state. For 
calculating QALYs it is necessary to transform the results onto a scale where 1 is full health 
and 0 is equivalent to death. To do this the worst SF-6D state was valued in a SG task where 
full health and dead was the uncertain prospect. This task yields a value ‘p’ for the worst state 
and this was used to transform the value of the six intermediate SF-6D health state valuations 
(SG) using the formula: SGADJ =SG+(1-SG)*P.  The transformed value SGADJ is used in 
all subsequent analyses.   
 
Modelling 
There were two modelling approaches applied to the data.  The classical parametric approach 
used by Brazier et al [3] and a more realistic and flexible nonparametric model [11].  
 
A general model for health state valuations can be described by: 
 ijjijij fy εα += ),(x ,   (1)  
where, for i = 1, 2, …, jn  and  j = 1,2, …, m, xij is the i
th health state valued by respondent j 
and the dependent variable yij is the adjusted SG score given by respondent j for that health 
state. The general model has two sets of independent, zero-mean, random effect terms: ijε  is a 
random error term associated with each observation and jα  is a term to allow for individual 
characteristics of respondent j.   
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The interpretation of ),( jijf αx  is as the true indifference SG value that respondent j has for 
health state ijx . The objective is to obtain a health state utility measure for the population as a 
whole, and this is generally taken to be the mean of the respondent-level health state values 
across the population.  In order to account for different populations, it is possible to model jα  
in terms of respondent-level covariates such as age, gender or socio-economic factors, but the 
principal objective of this study was to estimate a health state preference function for the 
population as a whole.   
 
The parametric approach  
Kharoubi et al [9] specify the following model for respondent j’s health state utility: 
jijjijf αµα +′+= )(),( xIx θ ,   (2) 
where µ  and θ  denote unknown parameters, )( ijxI  is a vector of dummy explanatory 
variables. In the simplest, no-interactions, case of this model, )( ijxI  is a vector of terms 
)( ijI xδλ  for each level λ > 1 of dimension δ of the SF-6D.  For example, )(32 ijI x  denotes 
dimension δ = 3 (social functioning), level λ = 2 (health limits social activities a little
ijx
 of the 
time).  For any given health state , )( ijI xδλ  is defined as: 
)( ijI xδλ  = 1 if, for state ijx , dimension δ is at level λ. 
)( ijI xδλ  = 0 if, for state ijx , dimension δ is not at level λ 
In all, there are 25 of these terms, with level λ = 1 acting as a baseline for each dimension. 
Hence the intercept parameter µ  represents the health state utility value for state 111111, and 
summing the coefficients δλθ  of the ‘on’ dummies derives the value of any other state.  
 9 
More generally, )( ijxI  can include additional dummy variables to account for interactions 
between the levels of different dimensions, and the model selected by Brazier et al [2] 
included one such interaction term, MOST, which takes the value of 1 if any dimension in the 
health state is at one of the most severe levels1
jα
, and 0 otherwise.   
Estimation of this random effects model is via generalised least squares or maximum 
likelihood.   Since  has zero mean, the population health state utility for state x in this 
model is simply )(xIθ ′+µ .  The other modelling approach has been to model mean health 
state values by OLS.  
 
The nonparametric approach  
Kharroubi and colleagues [9] built a new Bayesian statistical nonparametric model to describe 
the intrinsic characteristics of individual health state valuation data that is argued to be more 
theoretically appropriate than previous parametric models. For respondent j, the health state 
utility of state ijx  is 
 { })(1)exp(1),( ijjjij uf xx −−= αα  .  (3)  
Note that the individual respondent term jα  enters multiplicatively rather than additively as 
in (2).  The term u(x) is the median health state utility of health state x.2
                                                 
1 Most severe is defined as levels 4 to 6 for physical functioning, levels 3 and 4 for role limitation, 4 and 5 for 
social functioning, mental health and vitality, and 5 and 6 for pain. 
 
2 In the Kharroubi et al [11] model, the distribution of 
 It is treated as an 
unknown function and in a nonparametric framework it therefore becomes a random variable.  
The model for u(x) is 
jα  is normal, so it has zero median as well as zero mean, 
and the median of )exp( jα  is therefore 1. 
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u(x) ∼ ),(N 2σγ xβ′+ ,    (4) 
and furthermore the values of )(xu  and )(x′u  for two different states x and x′  have a 
correlation ),( xx ′c  which decreases as the distance between x and x′  increases.  The effect of 
this is to assert that if x and x′  describe very similar health states (in the sense that their levels 
are the same or close in all dimensions) their utilities will be approximately the same, and so 
the preference function varies smoothly as the health state changes.   
Note that the mean health state utility in (3) is  
 { })(11)( xx uu −−= α  , 
where α  is the mean value of )exp(α  over the whole population.  This will not in general be 
1, and so the population (mean) health state utility is not the same as the median health state 
utility u(x).  More details of the nonparametric modelling and evaluation of α  are given 
elsewhere [11]. 
 
Comparisons of models 
The parametric models have been judged in classical ways in order to allow comparison with 
the original UK study: the adjusted R2  (i.e. explanatory power); inconsistencies in the 
coefficient estimates (i.e. the main explanatory dummy variables are expected to be negative 
and increasing in absolute size and an inconsistent result occurs where a coefficient on the 
main effects dummies decreases in absolute size with a worse level); the mean absolute 
prediction error when the model is used to predict the actual mean values of each of the 241 
states valued (MAE) ; the number of prediction errors that are larger than 0.05 or 0.10 in 
absolute value: a t-test of the null hypothesis that the mean prediction error is zero (this is a 
test for bias in the predictions); Jarque-Bera test (JBPRED) for normality of the prediction 
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errors; Ljung-Box (LB) test for autocorrelation in the prediction errors. The LB test is for 
systematic variation in the prediction errors, signifying misspecification of the underlying 
model. 
  
The nonparametric model is compared to the parametric model in a number of ways.  The first 
is a plot of sample mean health state values alongside predicted mean values and residuals.  A 
better test of the validity of the model is to investigate its ability to predict the values for 
states that have not been used in the estimation. Data relating to 12 health states were 
removed from the estimation data, and the models fitted on data for the remaining 237 states. 
These 12 states were selected to be well spread over the health state space.  For both the 
parametric and non-parametric model results are compared in terms their ability to predict 12 
out of sample states, including the predicted mean health state values and their estimated 
standard deviations and mean root mean square error across the 12 states.  Finally Q-Q plots 
of standardised predictive errors for the out of sample mean health states values will be 
presented. The RE model has been selected as the parametric comparator since its 
specification is closest to the non-parametric model and because it is the most theoretically 
correct of the parametric models since it takes account of between and within respondent 
variation. 
 
THE DATA 
The total number of interviews conducted in the Japanese survey was 600.  To ensure 
comparability with the UK data set, the same exclusion criteria have been used:  respondents 
have been excluded who gave all states the same value (on the grounds that they did not 
understand the task) or where they did not value the worst state (since it is not possible to 
appropriately adjust their values).   Applying these criteria resulted in a total of 135 
 12 
exclusions.  The main analyses are based on the responses from the remaining 465 
respondents.  
 
The characteristics of those respondents included in the analysis are compared to those of the 
excluded cases in Table 2. There is little difference in the characteristics of cases included and 
those excluded in terms of their mean age, sex, marital status and proportion in full time 
employment.   The main difference is that excluded cases had a higher proportion with a poor 
understanding of the task, which is not surprising.  The characteristics of included 
respondents are comparable to those from the 2005 Japanese census for 18 to 75 year olds: 
mean age 46 (vs. 48), females 52% (vs. 54%) and employed was 56% (vs. 51%), although 
there was some difference in the proportion who were married 67 (vs. 75). [13] 
 
A further 185 health state values were missing, leaving a total of 3070 health state valuations.  
There were on average 12 valuations per state (excluding PITS which is valued by every 
respondent). This is slightly lower than the 14 per state achieved in the UK.  The distribution 
of individual values (SG) is similar in both countries and highly skewed and bi-modal.  Mean 
values from the Japanese survey range from 0.29 for worst state to 0.87 for 122122 with large 
standard deviations.  Median values usually exceed the mean health value reflecting the 
negative skewness in the data.   
 
In Japan the mean value for the worst state is 0.29 (SD 0.35), with only 20 respondents rating 
PITS as equal to being dead and 39 as worse than being dead (out of 465). The UK mean 
value was 0.21 (sdSD 0.43) with 73 respondents rating this state as equal to being dead and 
165 as worse (out of 611). 
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RESULTS 
Parametric model 
Results are presented for Japan for the OLS mean and RE individual level models with and 
without the intercept being restricted to unity.  The unrestricted models have intercepts 
significantly less than 1, which is contrary to theoretical expectations of the value of state 
111111. There are also a number of inconsistencies where worsening levels on each 
dimension do not attract larger decrements from full health. In some cases the coefficient 
estimates are approximately equal (e.g. PAIN5 and PAIN6), and in others the scale for that 
dimension does not have an obvious ordering (PF). However, the ROLE scale is overall 
ordinal, although RL 5 has a smaller coefficient that RL4.  
 
Restricting the intercept to unity (while theoretically justifiable) worsens the performance of 
the models by introducing more inconsistencies, creating larger prediction errors and 
prediction bias. In addition this restriction does not solve the autocorrelation problem with the 
errors which is a feature of all of the models reported here.  In both cases (restricted and 
unrestricted) the RE specification has fewer inconsistencies but larger prediction errors than 
the mean model. Figure 1 shows the impact of these problems by reporting the actual mean 
health state values alongside the predictions and errors from the random effects model.   This 
shows a systematic tendency for the parametric model to over predict for a large proportion of 
health states 
 
The models for the UK data generally perform better than the Japanese equivalents (Table 3). 
The unrestricted intercept is higher (though still significantly less than one), and there are 
fewer inconsistencies. Restricting the intercept to unity introduces a few more inconsistencies 
and systematic error in the predictions persists but in contrast to the Japanese data it does not 
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significantly increase the size of the prediction errors. The UK models also suffered from 
autocorrelation problems.   
 
Nonparametric 
The non-parametric model does not provide coefficients for parameters in the same way as 
shown on Table 3, so the model is reported in terms of its ability to predict health state values.  
Figure 2 presents the resulting predicted mean health state valuations for the Bayesian 
nonparametric model, along with actual mean health state valuations and the residuals. Figure 
1 presents the corresponding plots for the classical parametric model (1). These graphs 
indicate a significant improvement in predictive ability from the non-parametric model. In 
particular, the nonparametric model does not over predict the value for a large proportion of 
health states.  
 
There are other important differences between the models. The parametric model estimates 
the health state utility for the worst state to be 0.3917, even though the observed average for 
this state is 0.2903, whereas the nonparametric model achieves 0.292. Across the 249 states 
that were used in the study, the predictive performance of the nonparametric model is better 
than the parametric model overall, with a root mean square error (RMSE) of 0.089 for the 
nonparametric model compared to 0.133 for the parametric model. 
 
Data relating to 12 health states were removed from the estimation data, and the parametric 
and nonparametric models fitted on data for the remaining 237 states. Table 4 presents the 
true sample means for the 12 omitted states, together with their predicted mean and standard 
deviation values from the parametric and nonparametric models estimated on the reduced data 
set.  It can be seen that the Bayesian model predicts the omitted data quite well, and 
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substantially better than the parametric model with root mean squared prediction errors of 
0.0485 compared to 0.1186. The classical standard errors are larger than the Bayesian ones, 
primarily because the Bayesian analysis is able to make use of other evaluations by the same 
respondent to estimate their individual random effects.  Figures 3 and 4 show the Q-Q plots of 
standardised predictive errors for the 12 health states sample means, for the parametric and 
nonparametric models respectively. In each figure the straight line corresponds to the 
theoretical N (0,1) distribution. Figure 3 suggests that the standard model is not well validated 
by its predictive performance. In contrast, it is clear from Figure 4 that Bayesian model 
predictions are well validated as we are estimating the 12 out of sample health states more 
accurately than we were expecting. Our claim is fully justified by the results in Table 4. The 
mean of the standardised residuals for the parametric model is -0.834 compared to 0.29 for the 
Bayesian one, and 11 out of the 12 residuals from the standard model are negative. 
These 12 states were selected to be well spread over the health state space, but almost 
identical overall predictive results were obtained when omitted states were chosen at random.  
 
DISCUSSION 
This study has replicated the methods developed for estimating a preference-based measure 
for health in the UK for use in Japan.  The SF-6D had to be modified and so the sample of 
states used in the valuation survey were different.  The resultant data set has been analysed 
using classical parametric modelling methods and non-parametric models estimated using 
Bayesian methods developed on the UK data.   
 
While restricting the intercept to unity appears to worsen the statistical performance of the 
models, these restricted models are preferred for theoretical reasons concerning the value of 
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full health. Despite a detailed examination of alternative models, it was found the additive 
form could not be improved upon using parametric methods.  All parametric models had 
systematic prediction errors since the models under predict at the upper end and over predict 
values at the lower end.  Overall the findings are that the parametric models have not 
performed as well as their UK counterparts in terms of proportion of variation explained, the 
size of the errors and number of inconsistent pairs of coefficients. However, the models have 
produced significant coefficients on the main effects and many of the inconsistencies with the 
SF-6D are either understandable i.e. (PF5 is not necessarily worse than PF6) or the 
coefficients are actually very close.  Indeed looking at model 1d, there are only 5 
inconsistencies of more than 0.01 (excluding PF5).   
 
It is not clear why the Japanese models do not perform as well. It may be that the respondents 
in Japan found the SG questionnaire more difficult than their UK counterparts due to cultural 
differences.  Interestingly, this was not found in a recent SF-6D valuation study undertaken in 
Hong Kong. [14] 
 
There might be concerns about generalisability since the age of the sample only went up to 
75.  It has been shown that in the UK study that older people tend to give lower values to SF-
6D health states than younger people, particularly for more severe states  [15], but given over 
75s are just 10% of the general population this should not result in substantial differences. 
The exclusion of 22.5% of the sample might also be concerning, but these respondents were 
found to be comparable to those included respondents for all variables except understanding.   
 
Given the Japanese models did not perform as well as the UK models, and the previous 
findings that a non-parametric approach might improve the model [9], we decided to apply 
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this later method to the Japanese data.   This was shown to substantially improve the 
predictive performance of the model and so is the recommended method for generating a 
preference-base index from SF-36 data for use in Japan (available from authors).   
 
Nonetheless the classical parametric results are helpful in understanding some of the 
differences between UK and Japanese valuation.  The results clearly showed differences 
between the UK and Japanese samples.  The Japanese valuation of the worst state was 
significantly higher than for the UK (0.29 vs. 0.21).  Furthermore, the modelling revealed 
health dimensions had different relative weight underlying these overall differences. The 
physical functioning, role limitation and social functioning dimensions have larger 
decrements, whereas pain and mental health have smaller decrements than the UK models.  It 
is noticeable that there is little difference between levels 2 to 5 of the mental health 
dimension.   
 
The reasons for these differences with the UK are not clear, but are similar to the findings of 
the Japanese valuation of the EQ-5D [6].  The differences may arise from the translation not 
being linguistically equivalent, though this was minimised in earlier work with the SF-36.  
People in Japan may have a different attitude to risk rather than health per se, and this could 
explain the differences.  It is interesting that the differences between the UK and a Hong 
Kong general population sample were less and did not follow the same pattern [14].  These 
cross-cultural issues in health state valuation form an important research agenda for the 
future.  
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Table 1: The Short Form 6D 
 
Level Physical Functioning Level Pain 
1 Your health does not limit you in 1 vigorous activities You have no
2 
 pain 
Your health limits you a little in 2 vigorous activities You have pain but it does not interfere with your normal work (both 
outside the home and housework) 
3 Your health limits you a little in moderate activities 3   You have pain that interferes with your normal work (both outside 
the home and housework) 
4 
a little bit 
Your health limits you a lot in moderate activities 4   You have pain that interferes with your normal work (both outside 
the home and housework) 
5 
moderately 
Your health limits you a little in bathing and dressing 5   You have pain that interferes with your normal work (both outside 
the home and housework) 
6 
quite a bit 
Your health limits you 6 a lot in bathing and dressing You have pain that interferes with your normal work (both outside 
the home and housework) 
 
 
extremely 
 
Role limitations 
 
 
 
Mental health 
1 Due to your health, doing your work and other regular activities is not difficult 1 You feel tense or downhearted and low 
2 
none of the time 
Due to your health, doing your work and other regular activities is seldom 
difficult 
2 You feel tense or downhearted and low 
3 
a little of the time 
Due to your health, doing your work and other regular activities is sometimes 
difficult 
3 You feel tense or downhearted and low 
4 
some of the time 
Due to your health, doing your work and other regular activities is almost always  
difficult 
4 You feel tense or downhearted and low 
5 
most of the time 
Due to your health, doing your work and other regular activities is always 
difficult 
 
Social functioning 
5 You feel tense or downhearted and low 
1 
all of the time 
 
Vitality 
Your health limits your social activities 1 none of the time You have a lot of energy 
2 
all of the time 
Your health limits your social activities 2 a little of the time You have a lot of energy 
3 
most of the time 
Your health limits your social activities 3 some of the time You have a lot of energy 
4 
some of the time 
Your health limits your social activities 4 most of the time You have a lot of energy 
5 
a little of the time 
Your health limits your social activities 5 all of the time You have a lot of energy 
 
Footnote: The SF-36 items used to construct the SF-6D are as follows: physical functioning items1, 2 and 10; role limitation due to physical problems item 3; 
role limitation due to emotional problems item 2; social functioning item 2; both bodily pain items; mental health items 1 (alternate version) and 4; and 
vitality item 2.  
none of the time 
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Table 2: Survey information  
 
 Japan 
Interviews  600 
Excluded  
 For not valuing the worst   
            state 
63 (11%) 
 For giving same value to all 
states  
72 (12%) 
 For only valuing one state 0 
Included v. excluded  Inc. Exc.  
Mean age  48  44  
Female % 54 49 
Married % 75 73 
In FT employment % 51 49 
Poor understanding of taska 1 10 
  
 
a judged by interviewer 
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Table 3: Main valuation models for UK and Japan 
 Japan   UK 
 1a 1b 1c 1d  2a 2b 2c 2d 
  Mean RE Mean RE   Mean RE Mean RE 
C  0.740 0.746 1.000 1.000  0.827 0.833 1.000 1.000 
PF2 -0.033 -0.027 -0.084 -0.066  -0.014 -0.021 -0.060 -0.058 
PF3 -0.002 -0.007 -0.057 -0.041  0.008 -0.026 -0.020 -0.051 
PF4 -0.065 -0.069 -0.108 -0.093  -0.027 -0.065 -0.060 -0.088 
PF5 -0.028 -0.036 -0.078 -0.068  -0.043 -0.044 -0.063 -0.061 
PF6 -0.092 -0.105 -0.144 -0.137  -0.096 -0.135 -0.131 -0.160 
RL2 -0.013 -0.010 -0.062 -0.039  -0.019 -0.027 -0.057 -0.056 
RL3 -0.001 -0.019 -0.044 -0.044  -0.043 -0.055 -0.068 -0.076 
RL4 -0.075 -0.074 -0.122 -0.102  -0.036 -0.055 -0.066 -0.078 
RL5 -0.049 -0.067 -0.097 -0.092      
SF2 -0.005 -0.022 -0.070 -0.064  -0.027 -0.034 -0.071 -0.066 
SF3 -0.028 -0.032 -0.088 -0.074  -0.049 -0.022 -0.084 -0.048 
SF4 -0.044 -0.050 -0.101 -0.089  -0.057 -0.041 -0.093 -0.066 
SF5 -0.072 -0.098 -0.128 -0.128  -0.073 -0.089 -0.105 -0.109 
PAIN2 -0.006 -0.007 -0.069 -0.049  0.008 -0.001 -0.048 -0.042 
PAIN3 -0.007 -0.019 -0.064 -0.059  -0.001 -0.018 -0.034 -0.046 
PAIN4 -0.016 -0.042 -0.089 -0.087  -0.032 -0.026 -0.070 -0.055 
PAIN5 -0.056 -0.062 -0.115 -0.104  -0.062 -0.068 -0.107 -0.103 
PAIN6 -0.051 -0.093 -0.111 -0.129  -0.149 -0.155 -0.181 -0.178 
MH2 -0.040 -0.022 -0.099 -0.064  -0.026 -0.019 -0.057 -0.043 
MH3 -0.021 -0.017 -0.072 -0.050  -0.022 -0.032 -0.051 -0.055 
MH4 -0.036 -0.045 -0.090 -0.077  -0.095 -0.093 -0.121 -0.115 
MH5 -0.038 -0.049 -0.084 -0.072  -0.114 -0.106 -0.140 -0.125 
VIT2 -0.016 -0.002 -0.077 -0.046  -0.044 -0.006 -0.094 -0.040 
VIT3 -0.019 -0.014 -0.068 -0.049  -0.037 -0.008 -0.069 -0.030 
VIT4 -0.065 -0.023 -0.112 -0.057  -0.029 -0.011 -0.069 -0.040 
VIT5 -0.044 -0.031 -0.088 -0.055  -0.076 -0.068 -0.106 -0.087 
n 241 3070 241 3070  611 3518 611 3518 
Adj R2 0.305 0.123 0.018 b  0.583 0.200 0.508 b 
Inconsistencies  5 4 10 6  2 2 5 4 
MAE 0.067 0.068 0.082 0.111  0.071 0.073 0.074 0.078 
% > |0.05| 55 56 63 74  47 49 47 49 
%o > |0.10| 21 23 30 52  21 21 21 24 
t (mean=0) a -0.103 -2.962 -15.560  a 0.250  a -6.717 
JBPRED 2.816 3.146 0.135 0.741  0.737  1.178 0.681 2.461 
LB  944.20 779.02 129.42 288.72  520.71 386.63 169.57 185.3 
 
All models are estimated with White’s heteroscedasticity consistent standard errors.  
Estimates in bold are significant at t0.05.  
a Mean zero by definition.  
b No R2 statistics, GEE estimation.  
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Table 4: Out of sample predictions for 12 health states 
  
Nonparametric 
posterior inference Parametric inference 
Omitted 
state 
true 
sample 
mean mean (s.d.) mean 
 
 
(s.d.) 
122211 0.7761 0.7208 0.0694 0.8430 0.1135 
141651 0.5302 0.5556 0.0692 0.7107 0.0935 
212445 0.5954 0.6092 0.0654 0.6416 0.1034 
233551 0.5680 0.5041 0.0795 0.6425 0.1224 
312254 0.6824 0.6078 0.0609 0.7084 0.0946 
332122 0.5550 0.5832 0.0588 0.7444 0.0907 
411121 0.6355 0.6478 0.0658 0.8504 0.0930 
425212 0.6323 0.5682 0.0728 0.6446 0.1147 
511243 0.7502 0.7375 0.0682 0.7578 0.1142 
542524 0.3785 0.3982 0.0694 0.5417 0.0948 
623144 0.5711 0.5813 0.0653 0.5978 0.1033 
653444 0.5706 0.4759 0.0740 0.4527 0.3002 
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Figure 1. Sample mean and predicted health states valuations for the parametric model.  
Actual vs Predictive valuations
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Figure 2. Sample mean and predicted health states valuations for the nonparametric model. 
Actual vs Predictive valuations
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Figure 3.  Q-Q plot of standardised predictive errors for the parametric model for the 12 out of sample 
health states. 
 
Figure 4.  Q-Q plot of standardised predictive errors for the nonparametric model for the 12 out of 
sample health states. 
 
